Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Head and Neck Neoplasms 1Fatigue 1Cognitive Dysfunction 1Cancer Pain 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Oxycodone 5Morphine 5nabiximols 4Naloxone 2Fentanyl 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1naloxegol 1incobotulinumtoxinA 1Water 1Transcranial Direct Current Stimulation 1Tapentadol 1Sodium Bicarbonate 1Methadone 1Lidocaine 1Lenalidomide 1Ketamine 1Inosine Monophosphate 1Hydromorphone 1Glucose 1Donepezil 1Cognitive Behavioral Therapy 1Buprenorphine 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cancer Pain × Transcranial Direct Current Stimulation × Clear all
NCT02366611 2021-01-22

Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck Cancer

University of Michigan

Phase NA Completed
11 enrolled 9 charts
Head & Neck

Cancer Pain, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡